Marga Ortigas-Wedekind
Director/Board Member bei HEARTBEAM, INC.
Vermögen: 209 132 $ am 31.03.2024
Profil
Marga Ortigas-Wedekind is an Independent Director at HeartBeam, Inc. and a Director at Total Flow Cannula Ltd.
She is also the Chief Commercial Officer at Fogarty Innovation LLC since 2019.
Previously, she worked as a Marketing Director at Guidant Corp., Director at Itamar Medical Ltd., Director-Market Development at Guidant Vascular Intervention, EVP-Global Marketing & Product Development at Omnicell, Inc., SVP-Marketing, Development & Clinical Affairs at Xoft, Inc., Executive Vice President-Marketing at iRhythm Technologies, Inc., and Vice President-Sales & Marketing at Pro-Duct Health, Inc. Ms. Ortigas-Wedekind completed her undergraduate degree at Wellesley College and her MBA at Stanford Graduate School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
HEARTBEAM, INC.
0,36% | 13.07.2023 | 95 932 ( 0,36% ) | 209 132 $ | 31.03.2024 |
Aktive Positionen von Marga Ortigas-Wedekind
Unternehmen | Position | Beginn |
---|---|---|
HEARTBEAM, INC. | Director/Board Member | - |
Fogarty Innovation LLC | Corporate Officer/Principal | 01.12.2019 |
Total Flow Cannula Ltd.
Total Flow Cannula Ltd. Medical SpecialtiesHealth Technology Total Flow Cannula Ltd. develops novel medical devices. The Canadian company was founded in 2019 by Hillary Pierce and Luke Harris, with Hillary Pierce serving as CEO since 2019. | Director/Board Member | - |
Ehemalige bekannte Positionen von Marga Ortigas-Wedekind
Unternehmen | Position | Ende |
---|---|---|
IRHYTHM TECHNOLOGIES, INC. | Sales & Marketing | 01.07.2019 |
OMNICELL, INC. | Sales & Marketing | 01.04.2015 |
Xoft, Inc.
Xoft, Inc. Data Processing ServicesTechnology Services Xoft, Inc. develops Electronic Brachytherapy systems for radiation therapy applications. Its products include the Axxent Controller, which utilizes a miniaturized high dose rate (HDR) X-ray source to apply radiation directly to the cancerous tumor bed; Axxent HDR X-ray Source, a low energy radiation treatment without the use of radioactive isotopes; Axxent Applicators, which provides a channel for the Axxent X-ray Source to deliver high dose rate, low energy radiation directly to the targeted area; and Axxent Accessories, an accessory product line designed to support and aid a physician during a procedure or treatment of cancer radiation. The company was founded by Michael Forman in 1998 and is headquartered in San Jose, CA. | Chief Tech/Sci/R&D Officer | 01.12.2008 |
Guidant Vascular Intervention | Corporate Officer/Principal | 01.12.2000 |
ITAMAR MEDICAL LTD. | Director/Board Member | - |
Ausbildung von Marga Ortigas-Wedekind
Wellesley College | Undergraduate Degree |
Stanford Graduate School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
OMNICELL, INC. | Technology Services |
IRHYTHM TECHNOLOGIES, INC. | Health Technology |
HEARTBEAM, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Health Technology |
Xoft, Inc.
Xoft, Inc. Data Processing ServicesTechnology Services Xoft, Inc. develops Electronic Brachytherapy systems for radiation therapy applications. Its products include the Axxent Controller, which utilizes a miniaturized high dose rate (HDR) X-ray source to apply radiation directly to the cancerous tumor bed; Axxent HDR X-ray Source, a low energy radiation treatment without the use of radioactive isotopes; Axxent Applicators, which provides a channel for the Axxent X-ray Source to deliver high dose rate, low energy radiation directly to the targeted area; and Axxent Accessories, an accessory product line designed to support and aid a physician during a procedure or treatment of cancer radiation. The company was founded by Michael Forman in 1998 and is headquartered in San Jose, CA. | Technology Services |
Pro-Duct Health, Inc.
Pro-Duct Health, Inc. Medical SpecialtiesHealth Technology Pro·Duct Health manufactures the devices used in ductal lavage. The company is dedicated to eradicating breast cancer by enabling the earliest possible detection of breast pre-cancer and cancer | Health Technology |
Itamar Medical Ltd.
Itamar Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets the WatchPAT and EndoPAT products. The WatchPAT diagnoses sleep apnea, a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur in 1995 and is headquartered in Caesarea, Israel. | Electronic Technology |
Guidant Vascular Intervention | |
Fogarty Innovation LLC | |
Total Flow Cannula Ltd.
Total Flow Cannula Ltd. Medical SpecialtiesHealth Technology Total Flow Cannula Ltd. develops novel medical devices. The Canadian company was founded in 2019 by Hillary Pierce and Luke Harris, with Hillary Pierce serving as CEO since 2019. | Health Technology |